PCN42 MODELLING THE EFFECT OF A NOVEL THERAPEUTIC AGENT ON THE EVOLUTION OF UTILITY IN REFRACTORY MULTIPLE MYELOMA PATIENTS
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67280-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)67280-4/fulltext
Title :
PCN42 MODELLING THE EFFECT OF A NOVEL THERAPEUTIC AGENT ON THE EVOLUTION OF UTILITY IN REFRACTORY MULTIPLE MYELOMA PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67280-4&doi=10.1016/S1098-3015(10)67280-4
First page :
Section Title :
Open access? :
No
Section Order :
510